Natural History of the Progression of Choroideremia Study
Completed
Conditions studied: Choroideremia
In brief
The objective of this natural history study is to gain a better understanding of the progression of choroideremia (CHM) and add to the knowledge base for this rare disease.
Key facts
- Study ID
- NCT03359551
- Run by
- NightstaRx Ltd, a Biogen Company
- People needed
- 319
- Starts
- 2015-06-30
- Expected to finish
- 2020-10-01
- Last updated by the study team
- 2023-02-10
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Research Site — Los Angeles, California, United States
- Research Site — Miami, Florida, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — New York, New York, United States
- Research Site — Portland, Oregon, United States
- Research Site — Dallas, Texas, United States
- Research Site — Madison, Wisconsin, United States
- Research Site — São Paulo, Brazil
- Research Site — Edmonton, Alberta, Canada
- Research Site — Montreal, Canada
- Research Site — Vancouver, Canada
- Research Site — Glostrup Municipality, Denmark
- Research Site — Helsinki, Finland
- Research Site — Montpellier, France
- Research Site — Bonn, Germany
- Research Site — Tübingen, Germany
- Research Site — Nijmegen, Netherlands
- Research Site — London, United Kingdom
- Research Site — Manchester, United Kingdom
- Research Site — Oxford, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.